DNLI - Denali Therapeutics Inc.
IEX Last Trade
20.915
-0.415 -1.984%
Share volume: 0
Last Updated: Fri 27 Dec 2024 03:30:29 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$21.33
-0.42
-1.95%
Summary score
11%
Profitability
8%
Dept financing
4%
Liquidity
75%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-5%
Return on assets
-4.29%
Return on sales
-1350.3%
Return on invested capital
142.03%
Total debt ratio
22.87%
Debt ratio change over timeo
-1.16%
Current Ratio
12.01%
Quick Ratio
12.01%
Cash Position Ratio
11.73%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.65%
Return on assets
-9.2%
Return on sales
-8981.45%
Return on invested capital
-372.32%
Total debt ratio
8.97%
Debt ratio change over timeo
-1.24%
Current Ratio
13.49%
Quick Ratio
13.49%
Cash Position Ratio
13.05%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
-7.14%
Return on assets
-7.76%
Return on sales
0%
Return on invested capital
-19.82%
Total debt ratio
7.69%
Debt ratio change over time
-1.39%
Current Ratio
12.46%
Quick Ratio
12.46%
Cash Position Ratio
12.02%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-109.2%
Return on assets
-104.76%
Return on sales
-254.15%
Return on invested capital
-73.34%
Total debt ratio
-116.18%
Debt ratio change over time
-1.16%
Current Ratio
-28.89%
Quick Ratio
-28.89%
Cash Position Ratio
-28.31%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | DNLI | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -5% | 15.05% | 35.64% | 7.13% |
| Return on assets | -4.29% | 2.88% | 3.13% | 5.53% |
| Return on sales | -1350.3% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | 142.03% | 2.57% | 5.37% | 18.48% |
| Profitability | 25% | 42% | 60% | 58% |
| Total debt ratio | 22.87% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | -1.16% | 326.95% | -8.44% | 1.18% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 13.49% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 13.49% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 13.05% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 4% | 9% | 22% |
| Short-term ratios | DNLI | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.65% | 13.14% | 10.88% | 4.07% |
| Return on assets | -9.2% | 2.1% | 1.54% | 3.03% |
| Return on sales | -8981.45% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | -372.32% | 1.95% | 2.74% | 9.55% |
| Profitability | 0% | 65% | 56% | 83% |
| Total debt ratio | 8.97% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | -1.24% | 51.04% | -101.54% | 1.43% |
| Dept financing | 2% | 50% | 25% | 7% |
| Current Ratio | 13.49% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 13.49% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 13.05% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 4% | 9% | 24% |